Video yükleniyor...

Video Yüklenemedi

Ana Sayfaya Dön

🧬 What do HCPs need to know about current treatment options for advanced/recurrent EndometrialCancer? An animated MedEd video from Prof. Christian Marth 📺 Hear about 👉 A patient case study 👉 Latest treatment strategies 👉 A shift from traditional chemotherapy to personalised therapies driven by molecular profiling. This educational...

OBGynConnect's profile picture

OBSTETRICS & GYNECOLOGY CONNECT powered by COR2ED

2,399 subscribers

240,514 görüntüleme • 1 yıl önce •via X (Twitter)

Sağlık & İyilikBilim & TeknolojiEğitim
LIVE

Anya Rossi• Live Now

Private livecam show

0 Yorum

Yorum bulunmuyor

Orijinal gönderinin yorumları burada görünecek

Benzer Videolar

Advanced or recurrent endometrial cancer: Molecular classification & treatment decisions Medical experts Prof. Xavier Matias-Guiu G & Dr Jurjees Hasan explain the impact of molecular subtypes in treatment decisions in this video podcast 📺 Watch the video below Listen on all podcast platforms / get the transcript 👉 This programme has been sponsored by Eisai Europe Limited ("Eisai"). Eisai has had no input on the educational content of, or speakers involved in this Video Podcast.
11:28

Advanced or recurrent endometrial cancer: Molecular classification & treatment decisions Medical experts Prof. Xavier Matias-Guiu G & Dr Jurjees Hasan explain the impact of molecular subtypes in treatment decisions in this video podcast 📺 Watch the video below Listen on all podcast platforms / get the transcript 👉 This programme has been sponsored by Eisai Europe Limited ("Eisai"). Eisai has had no input on the educational content of, or speakers involved in this Video Podcast.

OBSTETRICS & GYNECOLOGY CONNECT powered by COR2ED

167,006 görüntüleme • 1 yıl önce

LEVIATHAN publication snapshot >> Expert insights on 2nd line treatment selection post atezolizumab + bevacizumab for HCC 📺 from Prof. David Pinato (David James Pinato 🇺🇦) >> Programme endorsed by European Liver Patients' Association, Blue Faery, Global Liver Institute & ESDO This programme is supported by an independent educational grant from Eisai Europe Limited. Eisai Europe Limited has financially supported this activity and has had no influence on its creation or content.
4:29

LEVIATHAN publication snapshot >> Expert insights on 2nd line treatment selection post atezolizumab + bevacizumab for HCC 📺 from Prof. David Pinato (David James Pinato 🇺🇦) >> Programme endorsed by European Liver Patients' Association, Blue Faery, Global Liver Institute & ESDO This programme is supported by an independent educational grant from Eisai Europe Limited. Eisai Europe Limited has financially supported this activity and has had no influence on its creation or content.

HCC CONNECT powered by COR2ED

701,778 görüntüleme • 8 ay önce

Explore the testing and treatment journey in 𝑁𝑇𝑅𝐾 fusion-positive lung cancer How can we use molecular testing to enable personalised care? 📺Find out in this educational video from Dr Herbert Loong (Herbert Loong, MBBS, FASCO) Endorsed by ICAN, International Cancer Advocacy Network & International Society of Liquid Biopsy Supported by an Independent Educational Grant from Bayer
5:27

Explore the testing and treatment journey in 𝑁𝑇𝑅𝐾 fusion-positive lung cancer How can we use molecular testing to enable personalised care? 📺Find out in this educational video from Dr Herbert Loong (Herbert Loong, MBBS, FASCO) Endorsed by ICAN, International Cancer Advocacy Network & International Society of Liquid Biopsy Supported by an Independent Educational Grant from Bayer

LUNG CONNECT powered by COR2ED

1,829,894 görüntüleme • 3 ay önce

Personalised treatment in childhood cancer: A journey through 𝘕𝘛𝘙𝘒 fusion testing 📺Video for patients & families – please share with your network From Linet Menachery, patient advocate and mother of a child diagnosed with an 𝘕𝘛𝘙𝘒 fusion-positive pediatric cancer Endorsed by NTRKers, ICAN, International Cancer Advocacy Network & Biomarker Collaborative Supported by an Independent Educational Grant from Bayer
4:51

Personalised treatment in childhood cancer: A journey through 𝘕𝘛𝘙𝘒 fusion testing 📺Video for patients & families – please share with your network From Linet Menachery, patient advocate and mother of a child diagnosed with an 𝘕𝘛𝘙𝘒 fusion-positive pediatric cancer Endorsed by NTRKers, ICAN, International Cancer Advocacy Network & Biomarker Collaborative Supported by an Independent Educational Grant from Bayer

COR2ED

5,214,734 görüntüleme • 7 ay önce

Lung cancer e-learning for HCPs Topic: the evolving TROP2-directed ADC landscape in metastatic NSCLC + strategies to optimise the treatment experience Endorsed by ICAN, International Cancer Advocacy Network, Exon 20 Group, a multistakeholder organization & Biomarker Collaborative Supported by an Independent Educational Grant from AstraZeneca 📹
1:15

Lung cancer e-learning for HCPs Topic: the evolving TROP2-directed ADC landscape in metastatic NSCLC + strategies to optimise the treatment experience Endorsed by ICAN, International Cancer Advocacy Network, Exon 20 Group, a multistakeholder organization & Biomarker Collaborative Supported by an Independent Educational Grant from AstraZeneca 📹

LUNG CONNECT powered by COR2ED

4,994,953 görüntüleme • 3 ay önce

📹 Discover the latest clinical practice changing insights from the ENETS 2026 conference in Krakow, Poland. Prof. Louis de Mestier, Prof. Timon Vandamme, and Dr Alice Durand share insights into new data on PRRT in treatment sequencing and re-challenge in NETs, obrixtamig as 1st line therapy in advanced NEC, and the role of surgery in stage 1–3 disease. In addition, they discuss interesting combination treatment. How will new data impact clinical practice? Watch to find out. This educational programme is supported by an Independent Educational Grant from Ipsen. The content published on this website is under the responsibility of its authors. Some scientific data published on this website may not have been validated by the relevant Marketing Authorisation Committees and should not be put into practice. It should be read and understood with the utmost discernment and is provided for the purpose of disseminating information on the current state of research to the international scientific community.
5:56

📹 Discover the latest clinical practice changing insights from the ENETS 2026 conference in Krakow, Poland. Prof. Louis de Mestier, Prof. Timon Vandamme, and Dr Alice Durand share insights into new data on PRRT in treatment sequencing and re-challenge in NETs, obrixtamig as 1st line therapy in advanced NEC, and the role of surgery in stage 1–3 disease. In addition, they discuss interesting combination treatment. How will new data impact clinical practice? Watch to find out. This educational programme is supported by an Independent Educational Grant from Ipsen. The content published on this website is under the responsibility of its authors. Some scientific data published on this website may not have been validated by the relevant Marketing Authorisation Committees and should not be put into practice. It should be read and understood with the utmost discernment and is provided for the purpose of disseminating information on the current state of research to the international scientific community.

NET CONNECT powered by COR2ED

1,109,837 görüntüleme • 6 ay önce

GI CONNECT podcast episode Tackling metastatic pancreatic ductal adenocarcinoma (mPDAC) Dr. Shubham Pant & Prof. Efrat Dotan MD discuss chemotherapy strategies that matter Conversation topics include: - Efficacy & safety profiles - Relevance of mode of delivery - Cause of toxicities - Strategies to manage side effects 📹 Highlights video in this post Endorsed by ICAN, International Cancer Advocacy Network Digestive Cancers Europe The National Pancreas Foundation PanCAN Supported by an Independent Educational Grant from Ipsen USA
4:31

GI CONNECT podcast episode Tackling metastatic pancreatic ductal adenocarcinoma (mPDAC) Dr. Shubham Pant & Prof. Efrat Dotan MD discuss chemotherapy strategies that matter Conversation topics include: - Efficacy & safety profiles - Relevance of mode of delivery - Cause of toxicities - Strategies to manage side effects 📹 Highlights video in this post Endorsed by ICAN, International Cancer Advocacy Network Digestive Cancers Europe The National Pancreas Foundation PanCAN Supported by an Independent Educational Grant from Ipsen USA

GI CONNECT powered by COR2ED

1,202,878 görüntüleme • 1 yıl önce

When should early treatment intensification w/ PARPi + ARPI combination be considered for mCRPC patients? 📺 Find out in this patient case video >> You’ll also discover the SHARE Communication Framework to use with your pts in clinical practice SHARE is made up of 5 key elements: S – Success criteria & aim of treatment H – How the treatments work A – Advantages/disadvantages of each Tx option R – Risks & effective management of side effects E – Expectations for Tx success Part 1 of the highlights video in this post ~ Endorsed by Urobel & ZERO Prostate Cancer Supported by an Independent Educational Grant from AstraZeneca
5:33

When should early treatment intensification w/ PARPi + ARPI combination be considered for mCRPC patients? 📺 Find out in this patient case video >> You’ll also discover the SHARE Communication Framework to use with your pts in clinical practice SHARE is made up of 5 key elements: S – Success criteria & aim of treatment H – How the treatments work A – Advantages/disadvantages of each Tx option R – Risks & effective management of side effects E – Expectations for Tx success Part 1 of the highlights video in this post ~ Endorsed by Urobel & ZERO Prostate Cancer Supported by an Independent Educational Grant from AstraZeneca

GU CONNECT powered by COR2ED

164,512 görüntüleme • 8 ay önce

Update from ESGO 2026 PYNNACLE Phase 2 study: Interim results from the ovarian cancer cohort Evaluating a first-in-class p53 reactivator, rezatapopt*, in TP53 Y220C–mutant advanced solid tumours 📺 Clinical insights and expert discussion from Profs Domenica Lorusso and Jean-Sebastien Frenel This programme has been sponsored by PMV Pharma and is intended for HCPs only. Brought to you by COR2ED Medical Affairs. *Rezatapopt is an investigational agent which is not approved by a regulatory agency
5:19

Update from ESGO 2026 PYNNACLE Phase 2 study: Interim results from the ovarian cancer cohort Evaluating a first-in-class p53 reactivator, rezatapopt*, in TP53 Y220C–mutant advanced solid tumours 📺 Clinical insights and expert discussion from Profs Domenica Lorusso and Jean-Sebastien Frenel This programme has been sponsored by PMV Pharma and is intended for HCPs only. Brought to you by COR2ED Medical Affairs. *Rezatapopt is an investigational agent which is not approved by a regulatory agency

COR2ED

5,788,637 görüntüleme • 7 ay önce

EP-NEC: What do you need to know about diagnosis, treatment, and support? ~ A video podcast discussion ~ Unlike most NETs, EP-NECs are poorly differentiated, high-grade, aggressive, and fast-growing cancers with, currently, a poor prognosis Medical Oncologist Dr Aman Chauhan & Neuroendocrine Patient Advocate Susan Meckler-Plummer, RN, address the key factors in managing this disease 📹 Highlights in this post Endorsed by Minkahz NETs Mission, Neuroendocrine Cancer UK #NotJustNECancer. Neuroendocrine Cancer Foundation and Neuroendocrine Cancer Research Foundation For more information or support, please speak with an HCP or reach out to a local patient advocacy group in your country or region Supported by an Independent Educational Grant from Boehringer Ingelheim
5:36

EP-NEC: What do you need to know about diagnosis, treatment, and support? ~ A video podcast discussion ~ Unlike most NETs, EP-NECs are poorly differentiated, high-grade, aggressive, and fast-growing cancers with, currently, a poor prognosis Medical Oncologist Dr Aman Chauhan & Neuroendocrine Patient Advocate Susan Meckler-Plummer, RN, address the key factors in managing this disease 📹 Highlights in this post Endorsed by Minkahz NETs Mission, Neuroendocrine Cancer UK #NotJustNECancer. Neuroendocrine Cancer Foundation and Neuroendocrine Cancer Research Foundation For more information or support, please speak with an HCP or reach out to a local patient advocacy group in your country or region Supported by an Independent Educational Grant from Boehringer Ingelheim

NET CONNECT powered by COR2ED

1,568,210 görüntüleme • 4 ay önce

Survey results published: Patient understanding of biomarker testing in non-small cell lung cancer (NSCLC) We surveyed patients & caregivers to assess awareness, knowledge & attitudes surrounding biomarker testing in NSCLC 📹 The results highlight gaps we can address to better support shared decision-making From medical experts Prof. Christian Rolfo , Prof. Fernando López-Ríos & Dr Rodrigo Paredes, MD , and made in collaboration with patient advocacy experts Dr. Amy C. Moore, Dr Anne-Marie Baird & Shani Shilo This programme is endorsed by LUNGevity Foundation, The Israeli Lung Cancer Foundation, NTRKers & Biomarker Collaborative Supported by an Independent Educational Grant from Bayer
1:07

Survey results published: Patient understanding of biomarker testing in non-small cell lung cancer (NSCLC) We surveyed patients & caregivers to assess awareness, knowledge & attitudes surrounding biomarker testing in NSCLC 📹 The results highlight gaps we can address to better support shared decision-making From medical experts Prof. Christian Rolfo , Prof. Fernando López-Ríos & Dr Rodrigo Paredes, MD , and made in collaboration with patient advocacy experts Dr. Amy C. Moore, Dr Anne-Marie Baird & Shani Shilo This programme is endorsed by LUNGevity Foundation, The Israeli Lung Cancer Foundation, NTRKers & Biomarker Collaborative Supported by an Independent Educational Grant from Bayer

LUNG CONNECT powered by COR2ED

2,703,909 görüntüleme • 3 ay önce

Navigating extrapulmonary neuroendocrine carcinoma (EP-NEC) >> This is a rare and complex cancer that needs early diagnosis and intervention 📺 Watch the video from Meredith Cummins, INCA President-Elect, and CEO of NeuroEndocrine Cancer Australia, to find out: -Why urgency is needed in diagnosis & treatment -The potential of investigational treatments -Where to find support Endorsed by: INCA (NET Cancer Day). NeuroEndocrine Cancer Australia, Neuroendocrine Cancer UK #NotJustNECancer, Neuroendocrine Cancer Foundation, Neuroendocrine Cancer Research Foundation & Minkahz NETs Mission Supported by an Independent Educational Grant from Boehringer Ingelheim
5:45

Navigating extrapulmonary neuroendocrine carcinoma (EP-NEC) >> This is a rare and complex cancer that needs early diagnosis and intervention 📺 Watch the video from Meredith Cummins, INCA President-Elect, and CEO of NeuroEndocrine Cancer Australia, to find out: -Why urgency is needed in diagnosis & treatment -The potential of investigational treatments -Where to find support Endorsed by: INCA (NET Cancer Day). NeuroEndocrine Cancer Australia, Neuroendocrine Cancer UK #NotJustNECancer, Neuroendocrine Cancer Foundation, Neuroendocrine Cancer Research Foundation & Minkahz NETs Mission Supported by an Independent Educational Grant from Boehringer Ingelheim

COR2ED

757,945 görüntüleme • 9 ay önce

Catch up on 𝘏𝘌𝘙2-mutant non-small cell lung cancer (NSCLC) data presented at ASCO 2026 Dr Herbert Loong, MBBS, FASCO & Dr Isabel Preeshagul joined us at ASCO 2026 to share their views on data emerging from the meeting 📺 Watch the video to get their expert insights on data from SOHO-01, Beamion LUNG-3, PRO results from the Beamion LUNG-1 trial, and advances in HER2 testing Programme endorsed by ICAN, International Cancer Advocacy Network, Biomarker Collaborative , Exon 20 Group, a multistakeholder organization & International Society of Liquid Biopsy Supported by an Independent Educational Grant from Bayer
4:40

Catch up on 𝘏𝘌𝘙2-mutant non-small cell lung cancer (NSCLC) data presented at ASCO 2026 Dr Herbert Loong, MBBS, FASCO & Dr Isabel Preeshagul joined us at ASCO 2026 to share their views on data emerging from the meeting 📺 Watch the video to get their expert insights on data from SOHO-01, Beamion LUNG-3, PRO results from the Beamion LUNG-1 trial, and advances in HER2 testing Programme endorsed by ICAN, International Cancer Advocacy Network, Biomarker Collaborative , Exon 20 Group, a multistakeholder organization & International Society of Liquid Biopsy Supported by an Independent Educational Grant from Bayer

LUNG CONNECT powered by COR2ED

841,885 görüntüleme • 2 ay önce

Giggle Academy : A Free Educational Platform for Every Child Giggle Academy is a free educational platform funded by Chinese-Canadian billionaire CZ 🔶 BNB The goal of the project is to provide basic education from grades 1 to 12 completely free of charge for every child, with a special focus on underserved areas where children have limited or no access to formal schooling. Giggle Academy’s curriculum covers essential subjects such as literacy, language, literature, mathematics, and science. Beyond core academics, Giggle Academy also introduces modern and advanced knowledge often missing from traditional systems — including programming, art, negotiation skills, personal finance, law, accounting, blockchain, and artificial intelligence. Caption : The video was edited and compiled by a team of reporters from the Voice of Vietnam (VoV)
3:14

Giggle Academy : A Free Educational Platform for Every Child Giggle Academy is a free educational platform funded by Chinese-Canadian billionaire CZ 🔶 BNB The goal of the project is to provide basic education from grades 1 to 12 completely free of charge for every child, with a special focus on underserved areas where children have limited or no access to formal schooling. Giggle Academy’s curriculum covers essential subjects such as literacy, language, literature, mathematics, and science. Beyond core academics, Giggle Academy also introduces modern and advanced knowledge often missing from traditional systems — including programming, art, negotiation skills, personal finance, law, accounting, blockchain, and artificial intelligence. Caption : The video was edited and compiled by a team of reporters from the Voice of Vietnam (VoV)

Niannian Community🔶️🐈

36,638 görüntüleme • 1 yıl önce

#WATCH | Delhi: On being asked about the future of the Indigenous Fighter aircraft programmes, Indian Air Force Air Chief Marshal AP Singh says, "I have been associated with the Tejas programme right from its flight testing days and it is very close to my heart. I know that this aircraft has the capability. It is a little too small of an aircraft for the current situation, however, we have such a place for an aircraft and we have ordered 200 plus aircraft of this type...We need to focus more towards the Mark 2 (aircraft) and Advanced Medium Combat Aircraft (AMCA) programme. We have the capacity and capability within the country to achieve this. Everybody has to come together to make it a success..."
1:16

#WATCH | Delhi: On being asked about the future of the Indigenous Fighter aircraft programmes, Indian Air Force Air Chief Marshal AP Singh says, "I have been associated with the Tejas programme right from its flight testing days and it is very close to my heart. I know that this aircraft has the capability. It is a little too small of an aircraft for the current situation, however, we have such a place for an aircraft and we have ordered 200 plus aircraft of this type...We need to focus more towards the Mark 2 (aircraft) and Advanced Medium Combat Aircraft (AMCA) programme. We have the capacity and capability within the country to achieve this. Everybody has to come together to make it a success..."

ANI

131,809 görüntüleme • 2 yıl önce

As a new report being spoken about on GB News tonight, pointing out that rape gangs are driven by islam, it's quite frustrating that this is exactly what I've been trying to tell the world for decades. In a sorry state of affairs, as I was censored from every single British TV, radio, and worldwide social media platforms, the only place I could exercise my freedom of speech was Russia, in an attempt to educate on Islamic rape jihad. Watch my educational seminar.
1:24:22

As a new report being spoken about on GB News tonight, pointing out that rape gangs are driven by islam, it's quite frustrating that this is exactly what I've been trying to tell the world for decades. In a sorry state of affairs, as I was censored from every single British TV, radio, and worldwide social media platforms, the only place I could exercise my freedom of speech was Russia, in an attempt to educate on Islamic rape jihad. Watch my educational seminar.

Tommy Robinson 🇬🇧

346,515 görüntüleme • 10 ay önce

EDU is unlocking a universe of learning! TinyTap welcomes #Web3 by adopting $EDU as a payment option to access over 250,000 educational games and interactive lessons. We believe in a future where every child has the means of entry and endless learning opportunities. Receive a 50% discount on subscriptions when you pay with EDU tokens for a limited time. 👉 Join TinyTap today, the web3 way. It's not just about accessing the world's largest library of educational games; it's about revolutionizing how we support and engage with education and those that provide it itself. By embracing EDU, we're inviting you to join us in a movement toward a more inclusive, accessible, and empowered future for learners and educators alike. Say goodbye to traditional barriers and hello to a world where education meets innovation. 🚀 📺 Watch how easy it is to get started with our quick guide on paying with EDU tokens. Let's build this future together. Open Campus Animoca Brands #EducationForAll #TinyTap #EducationGames #forkids #Web3Education
0:50

EDU is unlocking a universe of learning! TinyTap welcomes #Web3 by adopting $EDU as a payment option to access over 250,000 educational games and interactive lessons. We believe in a future where every child has the means of entry and endless learning opportunities. Receive a 50% discount on subscriptions when you pay with EDU tokens for a limited time. 👉 Join TinyTap today, the web3 way. It's not just about accessing the world's largest library of educational games; it's about revolutionizing how we support and engage with education and those that provide it itself. By embracing EDU, we're inviting you to join us in a movement toward a more inclusive, accessible, and empowered future for learners and educators alike. Say goodbye to traditional barriers and hello to a world where education meets innovation. 🚀 📺 Watch how easy it is to get started with our quick guide on paying with EDU tokens. Let's build this future together. Open Campus Animoca Brands #EducationForAll #TinyTap #EducationGames #forkids #Web3Education

TinyTap EDU | Speak with Eddy

37,873 görüntüleme • 2 yıl önce